Press release
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease, 120,000 with ulcerative colitis, and 15,000 with IBD type unclassified (IBD-U). CCC further estimates that seven out of every 1,000 Canadians has IBD. Moreover, by 2030, the number of people living with IBD is expected to rise to over 400,000, or nearly 1% of the population. The highest reported incidence of IBD is in Nova Scotia at 54.6 per 100,000 new cases per year, and the lowest is in British Columbia at 18.7 per 100,000 people per year.Get Free Sample Copy @ https://www.omrglobal.com/request-sample/canada-ibd-inflammatory-bowel-disease-market
Canada IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. Canada IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market.
A Full Report of Canada Inflammatory Bowel Disease (IBD) Market is Available at: https://www.omrglobal.com/industry-reports/canada-ibd-inflammatory-bowel-disease-market
The companies which are contributing to the growth of the Canada IBD market include Abbott Laboratories, AbbVie Inc., Accesa Labs, Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/canada-ibd-inflammatory-bowel-disease-market
Market Segmentation
Canada IBD Market Research and Analysis by Disease Type
Canada IBD Market Research and Analysis by Diagnostics
Canada IBD Market Research and Analysis by Therapeutics
Secondary Sources Include
Financial reports of companies involved in the market.
Whitepapers, research-papers, and news blogs.
Company websites and their product catalog.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025 here
News-ID: 2011196 • Views: …
More Releases from Orion Market Research

Chronic Low Back Pain (CLBP) Treatment Market - Current Impact to Make Big Chang …
The Chronic Low Back Pain (CLBP) Treatment Market was valued at USD 2.61 billion in 2023 and is expected to grow to approximately USD 6.82 billion by 2033, reflecting a CAGR of about 10.1% from 2024 to 2033.
Chronic Low Back Pain (CLBP) Treatment Market Overview
The Chronic Low Back Pain (CLBP) Treatment Market is experiencing significant growth due to the rising prevalence of chronic lower back pain, particularly among the aging…

Road Haulage Market: A Guide to Understanding the Process
The Road Haulage Market was valued at approximately USD 3.4 trillion in 2023 and is expected to grow to around USD 5.88 trillion by 2033, reflecting a CAGR of about 5.7% from 2024 to 2033.
Road Haulage Market Overview
The global road haulage market is witnessing steady growth, driven by increasing demand for efficient goods transportation and advancements in logistics technologies. Expansion in e-commerce and rising consumer expectations for faster delivery are…

Jewellery Market Global Rising Demand & Huge Scope Till 2033
The global jewelry market was valued at USD 353.26 billion in 2023 and is anticipated to reach approximately USD 578.45 billion by 2033, reflecting a CAGR of about 5.3% from 2025 to 2033 .
Jewellery Market Overview
The global jewellery market is experiencing steady growth, driven by evolving fashion trends, increasing consumer spending, and a rising preference for personalized and luxury accessories. Gold and diamond jewellery remain highly popular, while innovations in…

Artificial Kidney Market Share: In-Depth Analysis, Growth Opportunities, Key Tre …
In 2023, the global market was valued at approximately USD 1.5 billion and is projected to reach USD 5.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of 13% from 2023 to 2033.
Artificial Kidney Market Overview
The Artificial Kidney Market is experiencing strong growth due to the increasing prevalence of chronic kidney diseases and end-stage renal disease globally. Advances in dialysis technologies, including wearable and implantable devices, are improving…
More Releases for IBD
Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD An …
Ace Therapeutics launched its translational imaging services specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models.
New York, USA - May 28, 2025 - Ace Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies.
Image: https://www.getnews.info/uploads/3c0755ac659fa5075e809ffd1b893496.jpg
Imaging techniques play a crucial…
Inflammatory Bowel Disease (IBD) Market Size, Growth Insights, and Future Trends
Inflammatory Bowel Disease (IBD) continues to pose significant challenges for individuals and healthcare systems worldwide. With its increasing prevalence, the demand for effective treatments is driving market growth. The IBD treatment market is projected to grow from USD 19.91 billion in 2023 to USD 33.19 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period.
Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149
Key Market Highlights
• Crohn's Disease Dominates: Crohn's disease…
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,…
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx…
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per…
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and…